Nihon Kohden NKV-330 Ventilator System Receives FDA Clearance

Nihon Kohden OrangeMed, Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NKV-330 Ventilator System. The NKV-330 is a non-invasive ventilator that provides respiratory support to adult and pediatric patients. It offers not only non-invasive ventilation but also invasive ventilation as well as high-flow oxygen therapy. In addition, it provides continuous monitoring of CO2 when using our cap-ONE® NIV mask. The cap-ONE mask is an NIV interface that allows quality CO2 monitoring directly from the ventilator.

“The NKV-330 ventilator can help hospitals who face a limited choice of new non-invasive ventilator platforms,” said Dr. Hong-Lin Du, CEO of Nihon Kohden OrangeMed. “The continuous monitoring of CO2, the excellent portability, and many other features in the NKV-330 makes it a great choice for the hospitals and caregivers.”

The NKV-330 Ventilator System is distributed in the United States by Nihon Kohden America, Inc. and is expected to begin shipping in July 2022. It has been available outside of the United States since 2019.

For more information on the NKV-330 Ventilator System, please visit

Source: Nihon Kohden

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.